Expression of Cyclind1,p16 and Ki-67 in Papillomatosis and Ductal Carcinoma in Situ of the Breast

牛昀,刘铁菊,傅西林,于泳,吕阿娟
DOI: https://doi.org/10.3969/j.issn.1001-7399.2004.01.012
2004-01-01
Experimental Pathology
Abstract:To explore the clinicopathologic significance of the protein exprssion of cell cycle regulators cychinD1, p16, as well as proliferative cell nuclear antigen Ki-67 in papillomatosis and ductal carcinoma in site (DCIS) of the breast. Immunohistochemistry (IHC) was sued to deteinate the expression of cyclinD1, p16 an Ki-67 protein in 40 cases with mild papillomatiosis (MP), 40 cases with serious papillomatosis (S-P) and 40 caes with DCOS. The postive rats of cyclinD1 protein expression were 27.5% in MP, 50.0% in S-P and 60.0% in DCIS. respectively. There were significant ifference among the three groups (#chi#~(2)=8.929, P 0.05). Meanwhile the positive rates of Ki-678 showed significanlt differnces among three the groups or between any to groups by staistics (P<0.01 or P<0.05). The status of Ki-67 protein was psotivitley correlated to cyclinD1, conversely was negatively correlatd to p16, and cyclinD1 was negative by correlating to p16 expression. The abnormal expression of cyclinD1, p16, and cyclinD1 was negative by correlating to p16 expression. THe abnormal expression of cyclinD1, p16 and Ki-67 is early event in tumoringenesis of breast carcinoma. They play improtant roles in the devleopment of breast carcinoma. S-P is an important pre-cancerous lesion, which should be paid attention to culinical treatment. Regultaing the balance between cyclinD1 and p16 mignt be a pathway of genetherapy for pre-cancerous lesion.
What problem does this paper attempt to address?